Biological E plans to make 1.5 billion Corbevax jabs in 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.The vaccine, named PTX-COVID19-B, is under development in Canada and......

Producing vaccines is not like making 2 minutes noodles

'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar. IMAGE: A......

Govt to expand vaccination drive in coming days: Vardhan

Union Health Minister Harsh Vardhan on Friday said the COVID-19 vaccination drive will be extended in the coming days and asserted that there should not be any misconceptions about the two Indian......

COVID-19: Why everyone needs to be vaccinated

'At the stage where we are in today in the country, by the time mass vaccination becomes available, it would be around the middle of next year.''Most of those people, who got infected this year,......

Leaving its troubles behind, Shantha Biotechnics makes a fresh start

The biotech company's revenues had fallen to as low as Rs 50 cr after it lost a WHO contract, but now it hopes to reach Rs 700 cr in two years. It's sheer luck that made you succeed in an otherwise......

Can a condom maker churn out vaccines for the nation?

HLL, formerly Hindustan Latex Ltd, has been attempting to protect the nation against sexually transmitted diseases and unwanted pregnancies for decades -- its Nirodh condom is arguably one of the......

GSK Pharma scouts for domestic buys

GlaxoSmithKline Pharmaceuticals, the Indian arm of global drug major GlaxoSmithKline, is scouting for acquisitions in the domestic market to consolidate its Indian business. "We have a cash......

Now, a 4-in-1 vaccine from Shanta Biotech

Shantha Biotechnics Ltd on Friday announced the availability of 'Shantetra', a combination vaccine against diphtheria, tetanus, pertussis and hepatitis-B, claimed to be the first indigenously......